Paper39701599
CDCM: a correlation-dependent connectivity map approach to rapidly screen drugs during outbreaks of infectious diseases.
Liao J and 9 others. Brief Bioinform, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. CDCM: a correlation-dependent connectivity map approach to rapidly screen drugs during outbreaks of infectious diseases. Papers, record 39701599. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39701599
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CDCM: a correlation-dependent connectivity map approach to rapidly screen drugs during outbreaks of infectious diseases.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| SARS-CoV-2 | Major topic |
| Humans | |
| Disease Outbreaks | |
| Drug Discovery | |
| COVID-19 Drug Treatment | |
| Computational Biology | |
| Antiviral Agents | |
| Gene Regulatory Networks |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| XKJS-CRGRK-011 | Shenzhen High-level Hospital Construction Fund | PubMed | ||
| 2022B111010003 | Guangdong Province Science and Technology Plan Project "Biosafety Technology" Special Project | PubMed | ||
| 22N31900800 | Shanghai Science and Technology Innovation Action Plan | PubMed | ||
| JCYJ20230807143302004 | Shenzhen Science and Technology Innovation Commission Project | PubMed | ||
| 82070420 | National Natural Science Foundation of China | PubMed |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30624606 | Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing. | Bioinformatics | 2019 | https://conductscience.org/library/papers/30624606 | PubMed |
| 2 | 26428929 | Connectivity mapping uncovers small molecules that modulate neurodegeneration in Huntington's disease models. | J Mol Med (Berl) | 2016 | https://conductscience.org/library/papers/26428929 | PubMed |
| 3 | 30266498 | Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2. | Gene | 2019 | https://conductscience.org/library/papers/30266498 | PubMed |
| 4 | 34312227 | Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34312227 | PubMed |
| 5 | 19248973 | Cardiovascular effects of tyrosine kinase inhibitors used for gastrointestinal stromal tumors. | Hematol Oncol Clin North Am | 2009 | https://conductscience.org/library/papers/19248973 | PubMed |
| 6 | 24135855 | Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer. | J Cancer Res Clin Oncol | 2013 | https://conductscience.org/library/papers/24135855 | PubMed |
| 7 | 28699633 | Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. | Nat Commun | 2017 | https://conductscience.org/library/papers/28699633 | PubMed |
| 8 | 19017408 | Identifying differential correlation in gene/pathway combinations. | BMC Bioinformatics | 2008 | https://conductscience.org/library/papers/19017408 | PubMed |
| 9 | 33907519 | In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor. | Int J Biol Sci | 2021 | https://conductscience.org/library/papers/33907519 | PubMed |
| 10 | 34871905 | Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro. | Virology | 2022 | https://conductscience.org/library/papers/34871905 | PubMed |
| 11 | 31684108 | Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer. | Biomolecules | 2019 | https://conductscience.org/library/papers/31684108 | PubMed |
| 12 | 25606058 | Systematic evaluation of connectivity map for disease indications. | Genome Med | 2014 | https://conductscience.org/library/papers/25606058 | PubMed |
| 13 | 36229591 | Single-cell transcriptome analyses reveal distinct gene expression signatures of severe COVID-19 in the presence of clonal hematopoiesis. | Exp Mol Med | 2022 | https://conductscience.org/library/papers/36229591 | PubMed |
| 14 | 21226671 | Dasatinib: an anti-tumour agent via Src inhibition. | Curr Drug Targets | 2011 | https://conductscience.org/library/papers/21226671 | PubMed |
| 15 | 37533849 | Monkeypox: A real new warning or just a sign of times? | J Transl Int Med | 2023 | https://conductscience.org/library/papers/37533849 | PubMed |
| 16 | 27034707 | Pathogenic Network Analysis Predicts Candidate Genes for Cervical Cancer. | Comput Math Methods Med | 2016 | https://conductscience.org/library/papers/27034707 | PubMed |
| 17 | 39095457 | The pathogens that could spark the next pandemic. | Nature | 2024 | https://conductscience.org/library/papers/39095457 | PubMed |
| 18 | 25609570 | Compound signature detection on LINCS L1000 big data. | Mol Biosyst | 2015 | https://conductscience.org/library/papers/25609570 | PubMed |
| 19 | 29255791 | Drug discovery and development: Role of basic biological research. | Alzheimers Dement (N Y) | 2017 | https://conductscience.org/library/papers/29255791 | PubMed |
| 20 | 16207359 | Searching for differentially expressed gene combinations. | Genome Biol | 2005 | https://conductscience.org/library/papers/16207359 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41901341 | From a Multi-Omics Signature to a Therapeutic Candidate: Computational Prediction and Experimental Validation in Liver Fibrosis. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901341 | PubMed |
| 41362268 | Cross-Cell line transcriptome profiling reveals host-Virus interactions in monkeypox virus infection. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/41362268 | PubMed |
| 40945847 | Advances in high-throughput drug screening based on pharmacotranscriptomics. | J Adv Res | 2026 | https://conductscience.org/library/papers/40945847 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39701599
GET https://conductscience.org/api/papers/v1/39701599/references?page=2